###### Strengths and limitations of this study

-   This trial is the first investigation of the active behavioural physiotherapy intervention (ABPI) in patients with acute non-specific neck pain after finding potential benefits in patients with acute whiplash-associated disorder (WAD) in the previous Acute Whiplash Injury Study trial.

-   A mixed-method (quantitative and qualitative) trial will be performed to evaluate the procedures, feasibility and acceptability of the ABPI in managing acute non-specific neck pain within the Thai public hospitals.

-   The quantitative phase will be conducted using a cluster randomised double-blind (participants and assessors) design to avoid treatment contaminations and for administrative convenience.

-   The qualitative phase is designed to explore the treatment perceptions from all stakeholders, specifically patients and physiotherapists.

-   Although the ABPI was originally developed for managing patients with acute WAD, it may be helpful in patients with acute non-specific neck pain owing to the similar characteristics of both conditions.

Introduction {#s1}
============

Background and rationale {#s1-1}
------------------------

Neck pain is the fourth cause of disability[@R1] and the second biggest contributor to disability-adjusted life years among musculoskeletal disorders in the world.[@R2] Each year, approximately 50% of adults experience neck pain,[@R3] leading to a reduced quality of life (QoL).[@R4] Furthermore, the pain and disability associated with neck pain has a substantial impact contributing to social and economic burden (eg, healthcare utilisation, work absenteeism and lost productivity).[@R1] In the USA, the healthcare spending on the neck and back pain is approximately US\$86.7 billion, following diabetes and ischaemic heart disease.[@R6] For sickness absence in the UK, approximately 31 million days were lost due to musculoskeletal problems (mostly neck and back pain) among workers in 2016.[@R7] In Thailand, the fourth greatest health problem is musculoskeletal diseases (n=22 million people in 2015),[@R8] and up to 50% of these individuals' problems can be caused by neck pain,[@R8] leading to a socioeconomic burden of approximately 11 billion Thai baht.[@R10] Therefore, an effective intervention for managing neck pain is required to improve QoL and reduce socioeconomic burden.

Physical (eg, pain and disability)[@R1] and psychological (eg, anxiety, depression and fear avoidance)[@R11] problems are observed in patients with non-specific neck pain. The current clinical guidelines[@R14] and low-to-moderate quality evidence[@R16] suggest that manual and exercise therapy may be useful in managing patients with non-specific neck pain. However, high recurrence and chronicity among the patients with non-specific neck pain are reported, suggesting limited success of existing interventions.[@R1] For drug therapy, the recent systematic review and meta-analysis of randomised placebo controlled trials found that there were no effects of paracetamol for pain reduction, reducing disability and improving QoL,[@R20] and no clinical importance of non-steroidal anti-inflammatory drugs (NSAIDs) for spinal pain.[@R21] Additionally, the use of paracetamol (3000--4000 mg total) and NSAIDs (the median duration of included trial=7 days) are documented to contribute a 4 times increase in abnormal liver function[@R20] and 2.5 times increased the risk of gastrointestinal reactions, respectively.[@R21] Owing to these unwanted side effects from pharmacological management, non-specific neck pain is commonly managed by physiotherapists,[@R14] and effective conservative management in the acute stage (≤4 weeks)[@R11] is required to prevent the transition to chronicity and recurrence.

According to the current evidence, non-specific neck pain is a complex biopsychosocial disorder.[@R1] Subsequently, the management of patients with non-specific neck pain can be complex, encompassing both physical and psychological perspectives. All individuals with acute non-specific neck pain can be variously impacted by psychological problems, which can lead to poor recovery.[@R11] Unfortunately, using multimodal therapy or multifaceted implementation strategies to date have not been useful.[@R24] Although whiplash-associated disorders (WAD) and non-specific neck pain can be different in the mechanism of injury and severity, their conditions and clinical characteristics are similar.[@R24] An active behavioural physiotherapy intervention (ABPI) may, therefore, be useful in managing patients with non-specific neck pain based on the findings of the previous Acute Whiplash Injury Study (AWIS) pilot and feasibility trial.[@R28] The findings demonstrated that 95% of the patients who received the ABPI fully recovered at 3 months follow-up, whereas approximately 17% of the patients who received standard physiotherapy fully recovered using a cut-off on the Neck Disability Index (NDI) ≤4.[@R30] This suggests that the ABPI could prevent chronicity among the patients with WADII (≥3 months is classified as chronic stage).[@R33] Moreover, the ABPI appeared better than standard physiotherapy in terms of pain reduction (Visual Analogue Scale for pain intensity), cervical range of motion (CROM) (CROM device), pressure pain threshold (digital pressure algometer) and general health status (EuroQol-5 dimensions 5 levels (EQ-5D-5L)). Furthermore, the number of physiotherapy sessions and the costs of management in the ABPI arm were lower than standard physiotherapy.[@R32] The ABPI was acceptable to physiotherapists and patients, leading to the possibility for it enhancing physiotherapy practice in the future.[@R31]

Originally, the ABPI was developed through a sequential multiphase project using rigorous, precise and transparent methodologies in order to manage the patients with acute WAD.[@R28] The ABPI is a flexible complex intervention combining active physiotherapy and behavioural intervention (underpinned by social cognitive theory focusing self-efficacy enhancement).[@R28] It contains logical concept and phases (ie, understanding, maturity, stamina and coping) covering both physical and psychological management,[@R29] which seems to be suitable to address the problems in the patients with non-specific neck pain. Owing to no report of WAD as a health problem in Thailand but non-specific neck pain being a substantial problem[@R34] and possible value of the ABPI, the ABPI is, therefore, first investigate as a pilot and feasibility clinical trial in order to manage the patients with acute non-specific neck pain in a public Thai physiotherapy setting.

AIM {#s2}
===

To evaluate procedures, feasibility and acceptability of an ABPI for the management of patients experiencing acute non-specific neck pain in a Thai public physiotherapy setting in order to inform the design and sample size requirements for a future definitive randomised controlled trial (RCT).

Objectives {#s2-1}
----------

-   To evaluate the feasibility of procedures for a cluster RCT in the public physiotherapy sector in Thailand (ie, randomisation, recruitment, data collection, adherence, trial management and follow-up).[@R35]

-   To explore the acceptability of the ABPI among Thai physiotherapists (eg, ABPI contents, barriers to use, distinctiveness and acceptance) and patients (eg, received treatment and acceptance) with acute non-specific neck pain.[@R36]

-   To synthesise parameters to inform the sample size of an adequately powered definitive trial.[@R36]

Methods {#s3}
=======

Trial design and setting {#s3-1}
------------------------

The protocol follows the Standard Protocol Items: Recommendations for Interventional Trials to ensure adequate transparency.[@R41] This protocol contains two phases: (1) a quantitative study to evaluate the procedures and feasibility of the ABPI will follow research methods and reporting in line with the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement: extension to cluster randomised trials[@R42] and the CONSORT 2010 statement: extension to randomised pilot and feasibility trials[@R43]; and (2) an embedded exploratory qualitative study to investigate the acceptability of the ABPI of patients and physiotherapists in the ABPI arm will follow research methods and reporting of the Consolidated criteria for Reporting Qualitative research: a 32-item checklist for interviews and focus groups.[@R44] Subsequent deviations of the protocol will be submitted to the Naresuan University Institutional Review Board for an amendment and reported in the full trial.

Phase I: pilot and feasibility trial {#s3-2}
------------------------------------

A pilot and feasibility trial of a pragmatic cluster randomised double-blind (assessors and participants), parallel two-arm design, comparing ABPI with standard physiotherapy intervention (SPI), will be conducted to evaluate the procedures and feasibility of the ABPI for acute non-specific neck pain management. Six physiotherapy departments from the six public hospitals in Thailand will be recruited. The cluster randomisation design has several benefits in terms of reducing treatment contamination, enhancing participant adherence,[@R42] participant blinding,[@R42] administrative convenience[@R45] and logistical conveniences.[@R45]

The heads of six physiotherapy departments or their hospital directors will be invited to participate by signing consent forms (cluster-level consent) prior to cluster randomisation.[@R42] One physiotherapist and one blinded assessor (another physiotherapist who will be familiar with and trained for outcome measurements) will be provided by our research team in each hospital. Only physiotherapists, who will treat participants, will be informed their intervention arm. However, they will not be allowed to talk or discuss any concepts/treatments with the assessors, colleagues or other physiotherapists/people during the trial to ensure blinding assessors and participants. The physiotherapists can discuss with other physiotherapists within their intervention arm to provide an opportunity to exchange their experiences. Following randomisation, consecutive potential participants will be screened and recruited by physiotherapists. The participant information sheet and consent form will be given to potential participants. The recruiting physiotherapists will then discuss any issues relating to the trial, provide an opportunity to ask questions, confirm eligibility and obtain written consent (individual-level consent). After giving informed written consent, participants will be assessed on all outcome measures by blinded assessors at each site using the standardised instruments with established measurement properties. Assessments will be performed at this baseline and at 3 months follow-up postbaseline. All outcome assessments will be independent from treatment sessions to ensure the blinding of the assessors from treatment allocation. Additionally, the assessors will not be permitted to ask any question related to participants' received treatment from participants and treating physiotherapists throughout the trial. Both assessors and participants will not know to which intervention arm the participants are allocated. To evaluate blinding, at the end of the 3-month follow-up, participants and assessors will be asked which intervention they/their department have been allocated to in order to consider the blinded procedures of definitive phase III trial. The participants will receive a reminder 2 days prior to the 3-month follow-up appointment using email, message or telephone calling depending on their preference.

Phase II: qualitative semistructured interviews {#s3-3}
-----------------------------------------------

An embedded qualitative study using the interpretative phenomenological analysis (IPA)[@R48] will explore the acceptability of the ABPI for participants (n=12) and physiotherapists (all physiotherapists, n=3) in the ABPI arm.[@R30] There are several advantages of the IPA in terms of exploring personal experience, concerning personal perception, producing an objective statement and emphasising an active role for a research in dynamic process.[@R49] For convenience to interviewer and interviewees, semistructured interviews will be conducted by TW (a key person with physiotherapy background in developing the ABPI) who is the key to data quality from the interviews. His previous experiences and involvements are seen as positive rather than negative (eg, understanding of the context or the experiences of the interviewees).[@R50] Topic guides adapted from the AWIS trial[@R30] will be pilot tested 2--3 times prior to conducting the first interview. Potential participants will be recruited via telephone. The information sheet and consent form will be sent to them via email or post, depending on their preference in order to provide an opportunity to decide whether they wish to complete the consent form in advance. Demographic characteristics of the participants (eg, age, gender, occupation and ethnicity) will be recorded and reported.[@R44] The participants will be interviewed for 30--90 min in a private room of their local hospital. In the Thai context, we are not sure that the interviewees can provide a private room for the interviews in their homes. However, the interviewees will be paid for their journey to ensure that they are reimbursed for any expenses that they incur. The interviews will be recorded using a digital recorder.

Participants {#s3-4}
------------

Participants will be recruited from the physiotherapy departments of six public hospitals. Demographic characteristics, including age, gender, present medications and information regarding non-specific neck-pain symptoms, will be collected by the blinded assessors at the baseline assessment.

### Eligibility criteria for clusters {#s3-4-1}

Physiotherapy departments in public hospitals in Thailand.

### Inclusion criteria {#s3-4-2}

Participants aged 20--60 years presenting with non-specific neck pain within the previous 4 weeks.[@R11]

### Exclusion criteria {#s3-4-3}

Signs and symptoms WAD or traumatic neck pain,[@R51] upper cervical instability,[@R52] cervical artery dysfunction,[@R53] suspected serious spinal pathology, active inflammatory arthritis, tumours, infection of the skin and soft-tissue, bleeding disorders or using anticoagulant medication,[@R52] any current or previous treatment from any other third party, or presenting with any serious injuries, history of cervical surgery,[@R54] previously symptomatic degenerative diseases of the cervical spine or neck pain within 6 months prior to the recruitment,[@R55] neurological conditions, alcohol abuse,[@R55] dementia,[@R55] serious mental diseases,[@R55] psychiatric diseases,[@R57] osteoporosis, serious medical conditions (eg, severe diabetes and hypertension), pregnant and/or non-Thai speaking and reading.

Interventions {#s3-5}
-------------

Intervention details are provided in line with the Template for Intervention Description and Replication.[@R59] All participants will attend face-to-face physiotherapy for up to 10 sessions in a physiotherapy department based on their physiotherapist's clinical judgement. The frequency of appointment will depend on their physiotherapists' strategies but each session will be limited to 30 min. A minimum of a bachelor degree in physiotherapy with 5 years of postregistration experience will be required for the qualifications of all physiotherapists. TW will randomly select treatment sessions to observe and evaluate treatment fidelity. Also, this will enable provide an opportunity to monitor and provide a feedback regarding the intervention to the treating physiotherapists.[@R30]

### Standard physiotherapy intervention {#s3-5-1}

Patients will be managed according to current practice reflecting the recommendations provided in the non-specific neck pain clinical guidelines.[@R14] The SPI will consist of cervical or thoracic mobilisation/manipulation, exercises (eg, stretching, coordination, strengthening and endurance), upper quarter and nerve mobilisation, appropriate advice (eg, remain active as possible, restore their neck movement as pain allows using neck range of motion exercises, correct poor posture, sleep with one pillow which provides lateral support and also gives support to hollow of the neck), simple analgesia and other physiotherapy interventions (eg, manual therapy and modalities). All physiotherapists in the control arm will be trained and updated for the existing clinical guidelines to reach the standard physiotherapy management. Appropriate interventions will be selected depending on the physiotherapist's decision-making for the individual patient based on the examination findings and clinical reasoning.[@R53] Treatment sessions and notes will be randomly observed by TW to ensure adhering to the guidelines. Feedback and discussion will be provided throughout the trial.

### Active behavioural physiotherapy intervention {#s3-5-2}

The ABPI has been developed through a systematic review,[@R28] a modified Delphi study internationally,[@R29] use of social cognitive theory focusing on self-efficacy enhancement[@R61] and has been tested for WAD patients in an AWIS pilot and feasibility trial.[@R30] Full details of the ABPI (eg, concept, phases and strategies) are provided by the previous published articles.[@R29] The ABPI is delivered within a flexible framework, and will be modified to manage individuals with acute non-specific neck pain based on the clinical examination findings. The intervention will focus on reducing psychological stress and increasing confidence in exercises and/or home programmes using the self-efficacy enhancement at the beginning prior to improving physical functions based on the concept, phases and strategies of the ABPI.

Physiotherapists in the experimental arm will be trained to deliver the ABPI in advance of data collection. Training will consist of a group tutorial (1 day) and workshop followed by individual training sessions (4 weeks) to enable them to tailor the intervention to an individual patients with acute non-specific neck pain based on the findings from the patient history and physical examination data, and their evidence-informed clinical reasoning.[@R53] Physiotherapists and their treatment notes will be randomly observed by TW during data collection to ensure fidelity of the intervention and to provide feedback throughout the trial. Treatment fidelity will also be assessed by interviews from all physiotherapists (n=3) and participants (n=12) in the experiment group in an embedded qualitative study (phase II of this study).

Outcomes {#s4}
========

Planned definitive trial primary outcome measure {#s4-1}
------------------------------------------------

The NDI is a patient-reported questionnaire with 10 sections to evaluate pain intensity and functional activities (eg, personal care, lifting, reading, headache, concentration, work, driving, sleeping and recreation).[@R62] Each section is scored from 0 to 5 (the highest score representing the greatest disability). The NDI is a valid, reliable and responsive tool in assessing pain and disability in both acute and chronic neck problems.[@R62] The level of participant's disability will be indicated by the overall score.[@R62] The NDI version Thai has been reported as a reliable tool (Cronbach α=0.85, intraclass correlation coefficient (ICC)=0.85) in assessing the patients with neck pain, and will be used in this trial.[@R66] The minimum clinically importance difference (MCID) of the NDI in patients with neck pain is 8.[@R66]

Secondary outcome measures {#s4-2}
--------------------------

### Numerical Rating Scale for pain intensity {#s4-2-1}

Pain will be measured using a 0 (no pain) to 10 (worst possible pain) by the Numerical Rating Scale (NRS).[@R69] It is a simple and the preferred tool for assessing pain intensity, with high validity and reliability (ICC=0.76).[@R71] The MCID of NRS for patients with mechanical neck pain without upper limb symptoms is 1.5.[@R75]

### Cervical range of motion {#s4-2-2}

A common problem among the patients with neck pain is decreased cervical mobility.[@R76] In this trial, CROM will be measured using the CROM device.[@R77] The CROM device is reported as a highly valid and reliable (ICC~3,3~ ranging 0.89--0.98 for all neck movement directions) device in assessing CROM.[@R78] In the assessment process, participants will sit on a comfortable chair with both hips and knees flexed to 90° and be attached by the CROM device to the head.[@R79] The average of three measurements will be performed for data analysis. The MCID of CROM for non-specific neck pain is 10°.[@R82]

### Fear-Avoidance Beliefs Questionnaire {#s4-2-3}

Fear-Avoidance Beliefs Questionnaire (FABQ) is a valid and reliable tool to predict prolonged disability in patients with neck pain.[@R83] It consists of 16 items (each scored 0--6) covering both work and physical activity.[@R85] The FABQ has been translated into several languages (eg, Chinese, Persian and Greek) for patients with neck pain.[@R86] In Thailand, the translation and cross-cultural adaptation of the FABQ were conducted and tested the psychometric properties for Thai patients with non-specific neck pain (n=129) by TW and his colleagues. The findings reveal that the FABQ version Thai is a valid (Cronbach α=0.80--0.87 for all items) and reliable (ICC~2,1~=0.98) tool (preparing for publication) to quantify fear and avoidance beliefs in patients with non-specific neck pain. The minimum detectable change of the Thai version is 5.85. Unfortunately, the MCID of the FABQ is not available for patients with non-specific neck pain.

### EuroQol-5 dimensions 5 levels {#s4-2-4}

The EQ-5D-5L is a valid and reliable self-report QoL questionnaire.[@R89] It is recommended as a useful tool for measuring generic QoL in order to provide information for cost-effectiveness analysis.[@R92] The EQ-5D-5L has been translated into many languages including Thai and is valid and reliable tool (ICC~2,1~=0.70).[@R93] Unfortunately, the MCID of the EQ-5D-5L for non-specific neck pain is not available.

Assessment of outcome {#s4-3}
---------------------

All participants will be assessed at baseline and at 3 months postbaseline. Participants who continue with symptoms and problems after 3 months will be defined as chronic.[@R23] The number of fully recovered patients with non-specific neck pain at 3 months will be evaluated using a cut-off of NDI ≤4.[@R62] Telephone contact will be used by assessors in case of participants do not attend the 3-month follow-up assessment and they will be asked if they would like to make a new appointment. When participants cannot make a new appointment, the assessors will ask them to complete the NDI, NRS, FABQ and EQ-5D via telephone interview; however, these outcomes have established reliability and validity via telephone.[@R96]

Feasibility of cost-effectiveness analysis {#s4-4}
------------------------------------------

In order to assess the feasibility of data collection for the planned cost-effectiveness analysis in the definitive trial, direct and indirect medical costs will be collected and recorded. The diary pocket book of the previous AWIS trial[@R30] will be modified to Thai in order to record any activities related to non-specific neck pain management such as using medication, consulting other health professionals; along with any healthcare costs they incurred, and days of sick leave. The information will be collected by the blinded assessors each week replacing self-record, which was unsuccessful in the previous trial.[@R31] Furthermore, general information of participants (eg, work status, income and distance between home and hospital) will be collected at the baseline assessment. Costs related to physiotherapy management will be collected from the physiotherapy departments throughout the trial. Training costs of physiotherapists in the ABPI arm will be also included.

Sample size {#s4-5}
-----------

According to a pilot and feasibility trial, a power calculation is not required and targeted sample sizes for pilot/feasibility trials is still controversial.[@R36] However, 30 participants can be safely assumed to be normal distribution. Therefore, 60 participants (30 per arm, 10 from each department) will be recruited in order to provide parameters for designing a high quality of a definitive RCT.[@R99]

Randomisation {#s4-6}
-------------

Stata software V.12 with block sampling will be used by TW to randomise six physiotherapy departments to either SPI (n=3 departments) or ABPI (n=3 departments) in order to minimise selection bias at cluster level. The allocation will be concealed before assignment and only TW will involve in the process. Cluster randomisation will be performed prior to participant recruitment ([figure 1](#F1){ref-type="fig"}).

![CONSORT flow diagram (adapted from CONSORT 2010). CONSORT, Consolidated Standards of Reporting Trials.](bmjopen-2019-029795f01){#F1}

Data analysis {#s4-7}
-------------

### Phase I {#s4-7-1}

Quantitative data will be analysed and summarised to evaluate eligibility, recruitment and follow-up rates, using IBM SPSS V.22. The feasibility of the ABPI for non-specific neck pain management will be assessed using descriptive statistics (eg, frequencies, percentages, means, SD, medians and IQR depending on data).[@R37] Intention-to-treat analyses will be used in this trial and missing data will be reported descriptively. The evaluation of the number of fully recovered participants will be performed by consideration of NDI ≤4 at 3-month follow-up.[@R62] The ICC will be provided to calculate the sample size within a clustered definitive trial. The analyses and findings of the trial will be discussed with the research team at each stage, and by the trial steering and data monitoring committee.

After trial completion, the following are the possible decisions for progressing to a definitive trial: (1) stop if the main trial is not possible or valuable, (2) continue but modify the protocol if the main trial is possible and valuable, (3) continue without modifications but monitor closely if the main trial is possible and valuable with close monitoring and (4) continue without modifications if the main trial is possible and valuable.[@R37] [Table 1](#T1){ref-type="table"} shows the criteria to consider a future definitive trial.

###### 

Considerations for a future definitive trial

  Objectives                                                                                                                                                                                                                         Criteria for success
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  To evaluate the feasibility of procedures for a cluster randomised controlled trial in the public physiotherapy sector in Thailand (ie, randomisation, recruitment, data collection, adherence, trial management and follow-up).   Feasible to conduct a phase III trialNo major obstruction issue and/or serious adverse event (assessed by trial monitoring).Feasible for the type of study (randomised design) (assessed by trial monitoring).Feasible for procedures of data collection, trial management and follow-up (assessed by trial monitoring).At least three participants a month per hospital.
  To explore the acceptability of the ABPI among Thai physiotherapists and patients with acute non-specific neck pain.                                                                                                               The ABPI can be acceptable to Thai physiotherapists and patients with acute non-specific neck pain (explored by qualitative study).Acceptable rate ≥60% of participants in each group.
  To estimate sample size in order to conduct an adequately powered definitive trial.                                                                                                                                                All parameters can be provided to calculate sample size for an adequately powered definitive trial.

ABPI, active behavioural physiotherapy intervention.

### Phase II {#s4-7-2}

All interviews will be transcribed verbatim and analysed in line with IPA.[@R48] All participants will be anonymous using a pseudonym. Transcripts will be read a number of times to enable familiarisation. Qualitative data will be coded and grouped by TW and a coder to minimise potential bias. Related themes of the acceptability of the ABPI for non-specific neck pain management will be identified by QRS NVivo V.10. The analyses will be performed case by case in both deductively (to identify themes) and inductively (to identify additional themes).[@R100] After the completion of the initial coding, similarities of the themes between coders will be examined. Then, a table of emergent themes will be established. The process will be used throughout the study. The analysis and findings from the qualitative data will be reviewed and discussed with the research team and the trial management group to ensure the accuracy of data analysis and provide other interpretations and suggestions.

Trial management and monitoring {#s4-8}
-------------------------------

The trial management group (combing the trial steering committee and the data monitoring committee consistent with the pilot and feasibility nature of the trial) consisting of TW (the lead researcher), ABR (the experienced trialist), SU (the neck expert), a non-specific neck pain patient, an external member and an independent chair will meet at the start of recruitment, after 3 months of recruitment, and at the completion of the data collection.

Adverse events {#s4-9}
--------------

This trial can be considered as a low-risk trial for adverse event owing to no reporting of any adverse/serious adverse event by using the ABPI in physiotherapy setting of the previous AWIS trial.[@R30] Moreover, patients with non-specific neck pain have reported less severity than the patients with WAD. Both interventions are conservative treatments without existing reporting of serious adverse events in managing neck pain.[@R31] From the literature, the most common adverse event after physiotherapy intervention is muscle soreness and it can recover within 1--2 days.[@R105]

Serious adverse events {#s4-10}
----------------------

Serious adverse event can be evaluated as a very low risk owing to the nature of patient pathology and treatment management. This trial is designed to exclude patients with high severity using experienced physiotherapists who will be trained further in screening participants. Furthermore, the International Federation of Orthopaedic Manipulative Physical Therapists cervical framework,[@R53] which has provided guidance for clinical reasoning to identify the risk of adverse events regarding vascularity and instability of the neck, will be used to inform examination for eligibility. However, a serious adverse event will be defined if the participants have worsening symptoms within 3 days and have been admitted to the hospital due to non-specific neck pain problems.[@R30]

Procedures for reporting adverse and serious adverse events {#s4-11}
-----------------------------------------------------------

An adverse event reporting form will be provided to all physiotherapy departments. Participants will be required to report any unpleasant symptoms to their physiotherapists by completing the form. Then, physiotherapists will report any event to TW within 24 hours, and TW will report to the trial steering committee within 24 hours to enable analysis of the event and any required action. Any unexpected serious adverse events (eg, a life-threatening situation, inpatient hospitalisation and/or significant disability) will be immediately reported with a written form and verbal contact by physiotherapists to TW. Subsequently, TW will report any event to the trial steering committee; immediately to discuss for an action.

Data management {#s4-12}
---------------

A participant's data will be assigned an ID code, and the key relating participant to ID code will be stored securely and separately to the project files. All information of the participants will be preserved safely from any third party to maintain the participants' privacy at the Faculty of Allied Health Sciences, Naresuan University. All collected documents will be stored in a secure place and electronic data will be confidentially stored in a password-protected computer. Only members of the research team can access the data. All data will be securely destroyed after being kept for 10 years.

Patient and public involvement {#s4-13}
------------------------------

The trial is designed by a team of researchers using a part of the results from the previous pilot and feasibility trial, in which a patient was a member of the trial steering committee.[@R30] A patient will be planned to involve in this trial as a member of the trial management group. He/she will be thanked in the contributorship statement/acknowledgements in a full article.

Dissemination {#s4-14}
-------------

The findings of the trial (completely unattributable format or at an aggregate level) will be submitted to the medical journals and presented at the international and/or local conferences/lectures.

Discussion {#s5}
==========

The findings of the previous AWIS trial reported that the ABPI was feasible for acute WADII management to prevent the transition to chronicity (eg, 95% of the participants fully recovered by the ABPI within 3 months, whereas approximately 17% by the standard physiotherapy) and was acceptable to physiotherapists and patients.[@R30] Furthermore, physiotherapists have applied the ABPI to manage other neck pathologies and regions owing to the possible success of this management approach.[@R31] According to the similarity of the situations and symptom characteristics between the WAD and non-specific neck pain populations,[@R25] it is interesting to investigate if the ABPI is feasible for managing non-specific neck pain in the acute stage to prevent chronicity. Therefore, this phase II trial will be conducted to evaluate the feasibility and acceptability of the ABPI for acute non-specific neck pain in a Thai physiotherapy setting and/or to prepare information in designing an adequately powered, high-quality definitive trial.

This trial is designed to prevent potential problems resulting from some limitations of the previous AWIS trial.[@R30] First, this trial will provide one blinded assessor at each site to accelerate the recruitment rate and logistical convenience. Second, the trial will use individual semistructured in-depth interviews to explore the acceptability of the participants replacing a focus group. In the previous trial, only one participant could attend the focus group (three participants verbally agreed previously) although the research team tried to use several strategies (eg, contacting all participants, arranging based on their preference and convenience, reminding (2 days) for the date and location of the meeting prior to the date of the focus group and providing convenient facilities (eg, the nearest parking area and meals). Subsequently, the focus group was modified to an individual interview. Third, the qualitative data will be analysed using two independent coders to establish higher trustworthiness.

In Thailand, neck pain is a substantial health problem among musculoskeletal disorders leading to socioeconomic burden. Owing to the similar conditions and clinical characteristics between WAD and non-specific neck pain[@R25] and the findings of the AWIS trial,[@R31] the ABPI may be potentially effective intervention to manage acute non-specific neck pain. Thus, this trial will be conducted to evaluate the feasibility of the ABPI in patients with acute non-specific neck pain and its procedures. This trial is the first investigation of the ABPI in Thai clinical setting and the first time in conducting a cluster randomised design in Thai physiotherapy setting.
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